TIL therapy for melanoma generally involves excising a portion of the melanoma tumor, expanding TILs that show the tumor killing response in vitro with IL-2 and other growth factors, and intravenously infusing the TILs back into the patient (Figure 4) [91,92]. The gene discussed is IL2; the disease is neoplasm.